Prostate cancer market to reach $596.22m by 2028 | Healthcare Asia Magazine
Photo from Envato

Prostate cancer market to reach $596.22m by 2028

Thanks to a steady rise in clinical trials involving an innovator drug.

The prostate cancer market is projected to increase by 25% from $475.8m to $596.22m by 2028, said GlobalData.

The sector’s expansion is attributed to a steady rise in clinical trials involving an innovator drug and a growing portfolio of approved therapies over the past decade.

While there has been a slight dip in innovator trials and therapies in 2024, the report noted that the year is ongoing, leaving room for figures to recover and potentially surpass previous levels.

Meanwhile, diagnosed prevalent cases are forecasted to increase by 6.3% within the same period.

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

NUHCS to start using breakthrough drug for rare lung condition
Winrevair, which treats hypertension from constricted lung arteries, costs  $3,700-$6,730
Healthcare
Singapore’s aged care homes fall short
Their services are routinary and not personalised mainly due to resource constraints.
Healthcare
Electronic health records with AI show promise
They are also at risk from backdoor attacks, data poisoning and unauthorised access.